VaneJR: The release and fate of vasoactive hormones in the circula-tion. Br J Pharmacol35:209, 1969.
2.
SaidSI: Metabolic activity of the lung and its role in pulmonary disease. Clin Notes Resp Dis10:3, 1971.
3.
SaidSI: Metabolic events in the lung. In Pathophysiology: Altered Regulatory Mechanisms in Disease, section 2, FrohlichE.D. Ed., Philadelphia, J. B. Lippincott Co., 1972, p. 167.
4.
OrangeRP, AustenKF: Chemical mediators of immediate hyper-sensitivity. Hosp Prac6:79, 1971.
5.
IshizakaT, IshizakaK, OrangeRP, AustenKF: Pharmacologic inhibition of antigen-induced re-lease of histamine and slow-react-ing substance of anaphylaxis (SRS-A) from monkey lung tissues mediated by human IgE. J Immun106:1267, 1971.
6.
VaneJR: Mediators of the ana-phylactic reaction. In Identification of Asthma, Ciba Foundation, Study Group No. 38, Edinburgh and Lon-don, Churchill Livingstone, 1971, p. 121.
7.
PikeJE: Prostaglandins. Sci Amer225:84, 1971.
8.
HigginsCB, BraunwaldE: The prostaglandins, biochemical, phys-iologic and clinical considerations. Am J Med53:92, 1972.
9.
PiperP, VaneJR: The release of prostaglandins from lung and other tissues. Annals New York Academy Sciences (Conference on Pro-staglandins), 180:363, 1971.
10.
VaneJR: Prostaglandins and the aspirin-like drugs. Hosp Prac7:61, 1972.
11.
SaidSI, KitamuraS, MuttV: Biologically active polypeptides from the lung. In Chemistry and Biology of Peptides: Proceedings of the Third American Peptide Symposium, Boston, Mass.. June 1972, Ann Arbor Science Publish-ers, Inc., 1972.
12.
OmennGS: Ectopic polypeptide hormone production by tumors (Editorial). Ann Intern Med72:136, 1970.
13.
SanderGE, HugginsCG: Vasoactive peptides. Ann Rev Pharm12:227, 1972.
14.
IgicR, ErdosEG, YehHSJ, Sor-rellsK, NakajimaT: The angio-tensin I converting enzyme of the lung. Circ Res31: (Supplement 2,51), 1972.
WangNS, KotasRV, AveryME, ThurlbeckWM: Accelerated ap-pearance of osmiophilic bodies in fetal lungs following steroid injec-tion. J Appl Physiol30:362, 1971.
17.
SaidSI, HiroseT, FordW, KitamuraS, SiegelSR: Vasoactive intestinal polypeptide (VIP): a mediator of the hyperventilation of hepatic failure?Clin Res19:84, 1971.